IP Library › Granted Patent US 7,736,872
Granted Patent B2
US 7,736,872 · App. 11/292,903 · Granted Jun 15, 2010

Compositions of aminoacyl-TRNA synthetase and uses thereof

Assignee: Ambrx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,736,872
App. No.
11/292,903
Granted
Jun 15, 2010
Kind
B2
Abstract

Compositions and methods of producing components of protein biosynthetic machinery that include orthogonal tRNA's, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNA's/synthetases are provided. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins using these orthogonal pairs.

Claims (24)

1. A cell comprising a translation system, wherein the translation system comprises an aminoacyl tRNA synthetase (RS) encoded by the nucleic acid sequence consisting of SEQ ID NO: 4 and the complementary polynucleotide sequence of SEQ ID NO: 4.

2. The cell of claim 1 , wherein the cell is a eukaryotic cell.

3. The cell of claim 2 , wherein the eukaryotic cell is a yeast cell.

4. The cell of claim 2 , wherein the eukaryotic cell is a fungal cell.

5. The cell of claim 2 , wherein the eukaryotic cell is a mammalian cell.

6. The cell of claim 2 , wherein the eukaryotic cell is an insect cell.

7. The cell of claim 2 , wherein the eukaryotic cell is a plant cell.

8. The cell of claim 1 , wherein the cell is a non-eukaryotic cell.

9. The cell of claim 8 , wherein the non-eukaryotic cell is an E. coli cell.

10. The cell of claim 1 , further comprising a tRNA that is aminoacylated by said RS and a polynucleotide encoding a polypeptide of interest, wherein the polynucleotide comprises a selector codon that is recognized by the tRNA.

11. The cell of claim 10 , wherein said polypeptide of interest is human growth hormone.

12. The cell of claim 1 , wherein the cell is an E. coli cell.

13. A vector comprising a polynucleotide sequence encoding an RS where the polynucleotide sequence consists of SEQ ID NO: 4, and the complementary polynucleotide sequence thereof.

14. The vector of claim 13 , wherein the vector comprises a plasmid, a cosmid, a phage, or a virus.

15. The vector of claim 13 , wherein the vector is an expression vector.

16. A cell comprising the vector of claim 13 .

17. A method of producing a polypeptide in a cell with a selected amino acid at a specified position, the method comprising:

growing, in an appropriate medium, the cell, where the cell comprises a nucleic acid that comprises at least one selector codon and encodes a polypeptide; and,

providing the selected amino acid;

wherein the cell further comprises: an orthogonal RS (O-RS) that functions in the cell wherein said O-RS is encoded by a polynucleotide sequence consisting of SEQ ID NO: 4 and the complementary polynucleotide sequence thereof, and,

an orthogonal tRNA (O-tRNA), that recognizes the selector codon wherein said O-RS aminoacylates the O-tRNA with the selected amino acid.

18. The method of claim 17 wherein said selected amino acid is para-acetyl phenylalanine.

19. The method of claim 17 wherein said polypeptide is human growth hormone.

20. An isolated polynucleotide consisting of the nucleic acid sequence SEQ ID NO: 4, and the complementary polynucleotide sequence thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2006
From: PAULSEL, ANDREW; CHO, HO SUNG
To: AMBRX, INC.
Reel/Frame 017577/0183 →
Continuity (2)
Provisional Application 6063914600 · Dec 22, 2004
Related Publication 20090123971A1 · May 14, 2009